HEADER CYTOKINE 14-DEC-07 2JYO TITLE NMR SOLUTION STRUCTURE OF HUMAN MIP-3ALPHA/CCL20 COMPND MOL_ID: 1; COMPND 2 MOLECULE: C-C MOTIF CHEMOKINE 20 (SMALL-INDUCIBLE CYTOKINE A20) COMPND 3 (MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA) (MIP-3-ALPHA) (LIVER AND COMPND 4 ACTIVATION-REGULATED CHEMOKINE) (CC CHEMOKINE LARC) (BETA CHEMOKINE COMPND 5 EXODUS-1); COMPND 6 CHAIN: A; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS PROTEIN, CHEMOKINE, CYTOKINE, ALTERNATIVE SPLICING, ANTIBIOTIC, KEYWDS 2 ANTIMICROBIAL, CHEMOTAXIS, INFLAMMATORY RESPONSE, POLYMORPHISM, KEYWDS 3 SECRETED EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR D.I.CHAN,H.N.HUNTER,B.F.TACK,H.J.VOGEL REVDAT 5 14-JUN-23 2JYO 1 REMARK REVDAT 4 19-FEB-20 2JYO 1 REMARK REVDAT 3 24-FEB-09 2JYO 1 VERSN REVDAT 2 24-JUN-08 2JYO 1 JRNL REVDAT 1 01-JAN-08 2JYO 0 JRNL AUTH D.I.CHAN,H.N.HUNTER,B.F.TACK,H.J.VOGEL JRNL TITL HUMAN MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA: PROTEIN AND JRNL TITL 2 PEPTIDE NUCLEAR MAGNETIC RESONANCE SOLUTION STRUCTURES, JRNL TITL 3 DIMERIZATION, DYNAMICS, AND ANTI-INFECTIVE PROPERTIES. JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 52 883 2008 JRNL REFN ISSN 0066-4804 JRNL PMID 18086840 JRNL DOI 10.1128/AAC.00805-07 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA, CNS 1.1 REMARK 3 AUTHORS : LINGE, J.P. ET AL. (ARIA), BRUNGER, A.T. ET AL. REMARK 3 (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IN TOTAL, 2362 RESTRAINTS WERE USED: REMARK 3 1827 UNAMBIGUOUS NOE RESTRAINTS, 455 AMBIGUOUS RESTRAINTS, 64 REMARK 3 BROAD DIHEDRAL RESTRAINTS AND 16 HYDROGEN BONDING RESTRAINTS. REMARK 4 REMARK 4 2JYO COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000100455. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 4.2 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.9 MM PROTEIN, 90% H2O/10% D2O; REMARK 210 0.9 MM PROTEIN, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 2D DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW 5.0.4, XWINNMR 3.0, 3.5 REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TYR A 10 -167.49 -79.92 REMARK 500 2 CYS A 6 150.80 -46.37 REMARK 500 2 ASP A 12 74.23 -118.54 REMARK 500 3 ASP A 12 68.90 -108.02 REMARK 500 3 ALA A 28 35.03 -83.58 REMARK 500 3 ASN A 29 -52.62 -132.73 REMARK 500 3 PRO A 51 21.33 -72.01 REMARK 500 4 ASP A 5 -104.44 -112.03 REMARK 500 4 TYR A 10 -160.12 -100.58 REMARK 500 4 ASP A 12 69.23 -118.55 REMARK 500 4 ASN A 29 -64.61 -100.26 REMARK 500 4 PRO A 51 -8.19 -57.33 REMARK 500 4 SER A 64 -63.38 -108.35 REMARK 500 4 LYS A 65 78.33 -101.72 REMARK 500 4 ASN A 69 -80.97 -112.65 REMARK 500 5 ASP A 12 14.19 -147.27 REMARK 500 5 CYS A 32 -153.69 -120.06 REMARK 500 6 ASN A 69 -82.95 -132.01 REMARK 500 7 ASP A 12 59.53 -95.19 REMARK 500 7 ALA A 28 32.82 -78.04 REMARK 500 7 PRO A 51 39.16 -89.76 REMARK 500 7 LYS A 52 -80.79 -131.97 REMARK 500 7 SER A 64 52.43 -96.23 REMARK 500 7 LYS A 65 103.27 -56.18 REMARK 500 7 ASN A 69 -51.62 -130.92 REMARK 500 8 CYS A 6 142.09 -36.35 REMARK 500 8 THR A 11 -166.26 -107.38 REMARK 500 8 ASP A 12 81.42 -160.22 REMARK 500 9 ASN A 3 -72.14 -74.46 REMARK 500 9 PHE A 4 -42.85 -130.77 REMARK 500 9 ASP A 5 -34.91 -141.05 REMARK 500 9 LEU A 8 25.70 -77.34 REMARK 500 9 ALA A 28 46.84 -77.83 REMARK 500 9 PRO A 51 32.16 -88.91 REMARK 500 9 LYS A 52 -61.43 -132.25 REMARK 500 10 CYS A 6 142.31 -38.60 REMARK 500 10 ASP A 12 23.37 -144.83 REMARK 500 10 ILE A 14 77.69 -117.71 REMARK 500 11 CYS A 6 -179.85 -60.43 REMARK 500 11 ASP A 12 16.57 -141.23 REMARK 500 12 CYS A 6 150.84 -38.08 REMARK 500 12 ASP A 12 56.65 -101.97 REMARK 500 12 PRO A 51 23.47 -73.20 REMARK 500 13 CYS A 6 142.55 -35.62 REMARK 500 13 LEU A 8 45.34 -81.93 REMARK 500 13 ASP A 12 31.18 -144.78 REMARK 500 13 LYS A 66 97.89 -68.77 REMARK 500 14 ASP A 5 -93.10 -128.79 REMARK 500 14 ASN A 29 -73.42 -99.41 REMARK 500 14 LYS A 65 86.67 -60.12 REMARK 500 REMARK 500 THIS ENTRY HAS 84 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HA6 RELATED DB: PDB REMARK 900 MOUSE MIP-3ALPHA/CCL20 REMARK 900 RELATED ID: 1M8A RELATED DB: PDB REMARK 900 HUMAN MIP-3ALPHA X-RAY STRUCTURE REMARK 900 RELATED ID: 2HCI RELATED DB: PDB REMARK 900 HUMAN MIP-3ALPHA X-RAY STRUCTURE REMARK 900 RELATED ID: 15596 RELATED DB: BMRB DBREF 2JYO A 1 70 UNP P78556 CCL20_HUMAN 27 96 SEQRES 1 A 70 ALA SER ASN PHE ASP CYS CYS LEU GLY TYR THR ASP ARG SEQRES 2 A 70 ILE LEU HIS PRO LYS PHE ILE VAL GLY PHE THR ARG GLN SEQRES 3 A 70 LEU ALA ASN GLU GLY CYS ASP ILE ASN ALA ILE ILE PHE SEQRES 4 A 70 HIS THR LYS LYS LYS LEU SER VAL CYS ALA ASN PRO LYS SEQRES 5 A 70 GLN THR TRP VAL LYS TYR ILE VAL ARG LEU LEU SER LYS SEQRES 6 A 70 LYS VAL LYS ASN MET HELIX 1 1 GLN A 53 LYS A 65 1 13 SHEET 1 A 3 ILE A 20 GLN A 26 0 SHEET 2 A 3 ALA A 36 THR A 41 -1 O ILE A 38 N THR A 24 SHEET 3 A 3 SER A 46 ALA A 49 -1 O VAL A 47 N PHE A 39 SSBOND 1 CYS A 6 CYS A 32 1555 1555 2.03 SSBOND 2 CYS A 7 CYS A 48 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1